Programming infant gut microbiota: Influence of dietary and environmental factors

Current Opinion in Biotechnology

Volumn 21, Issue 2, 2010, Pages 149-156

  Marques, Tatiana Milena ^a,b,c   Wall, Rebecca ^a   Ross, R Paul ^a,b   Fitzgerald, Gerald F ^a,c   Ryan, C Anthony ^c   Stanton, Catherine ^a,b  

^a UNIVERSITY COLLEGE CORK   (Ireland)

^b TEAGASC FOOD RESEARCH CENTRE   (Ireland)

^c UNIVERSITY COLLEGE CORK   (Ireland)

Author keywords

[No Author keywords available]

Indexed keywords

COLONISATION; EARLY LIFE; ENVIRONMENTAL FACTORS; IMMUNE SYSTEMS; MICROBIAL ORGANS; MICROBIOTAS;

ECOLOGY;

4 AMINOBUTYRIC ACID; ANTIBIOTIC AGENT; BUTYRIC ACID; CONJUGATED LINOLEIC ACID; CYANOCOBALAMIN; FARNOQUINONE; POLYSACCHARIDE; PREBIOTIC AGENT; PROBIOTIC AGENT; SHORT CHAIN FATTY ACID; SYNBIOTIC AGENT;

ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; BACTERIAL COLONIZATION; BACTERIAL METABOLISM; BREAST FEEDING; CANCER PREVENTION; COLON CANCER; DIARRHEA; DIET; DIET SUPPLEMENTATION; DRUG EFFICACY; DRUG SAFETY; ENTERITIS; ENVIRONMENTAL FACTOR; HOST PATHOGEN INTERACTION; HUMAN; IMMUNOMODULATION; INTESTINE FLORA; MICROBIAL COLONIZATION; MICROBIAL COMMUNITY; MUCOSAL IMMUNITY; NECROTIZING ENTEROCOLITIS; NONHUMAN; PRIORITY JOURNAL; REVIEW;

DIET; ECOSYSTEM; FOOD MICROBIOLOGY; HUMANS; INFANT, NEWBORN; INTESTINES;

EID: 77952670363     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.copbio.2010.03.020     Document Type: Review

References (78)

1. O' Toole P.W., Claesson M.J. Gut microbiota: changes throughout the lifespan from infancy to elderly. Int Dairy J 2010, 20:281-291.
2. Gronlund M.M., Lehtonen O.P., Eerola E., Kero P. Fecal microflora in healthy infants born by different methods of delivery: permanent changes in intestinal flora after caesarean delivery. J Pediatr Gastroenterol Nutr 1999, 28:19-25.
3. Orrhage K., Nord C.E. Factors controlling the bacterial colonization of the intestine in breast-fed infants. Acta Pediatr 1999, 430:S43-S54.
4. Kalenic S., Francetic I., Polak J., Zele-Starcevic L., Bencic Z. Impact of ampicillin and cefuroxime on bacterial colonisation and infection in patients on a neonatal intensive care unit. J Hosp Infect 1993, 23:35-41.
5. Burman L.G., Berglund B., Huovinen P., Tullus K. Effect of ampicillin versus cefuroxime on the emergence of beta-lactam resistance in fecal Enterobacter cloacae isolates from neonates. J Antimicrob Chemother 1999, 31:111-116.
6. Palmer C., Bik E.M., DiGiulio D.B., Relman D.A., Brown P.O. Development of the human infant intestinal microbiota. PLoS Biol 2007, 5:e177.
7. Wang M., Ahrne S., Antonsson M., Molin G. T-RFLP combined with principal component analysis and 16S rRNA gene sequencing: an effective strategy for comparison of fecal microbiota in infants of different ages. J Microbiol Method 2004, 59:53-69.
8. Hopkins M.J., Macfarlane G.T., Furrie E., Fite A., Macfarlane S. Characterisation of intestinal bacteria in infant stools using real-time PCR and northern hybridisation analyses. FEMS Microbiol Ecol 2005, 54:77-85.
9. Sakata S., Tonooka T., Ishizeki S., Takada M., Sakamoto M., Fukuyama M., Benno Y. Culture-independent analysis of fecal microbiota in infants, with special reference to Bifidobacterium species. FEMS Microbiol Lett 2005, 243:417-423.
10. Penders J., Thijs C., Vink C., Stelma F.F., Snijders B., Kummeling I., van den Brandt P.A., Stobberingh E.E. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006, 118:511-521.
11. Rajilic-Stojanovic M., Heilig H.G.H.J., Molenaar D., Kajander K., Surakka A., Smidt H., de Vos W.M. Development and application of the human intestinal tract chip, a phylogenetic microarray: analysis of universally conserved phylotypes in the abundant microbiota of young and elderly adults. Environ Microbiol 2009, 11:1736-1751.
12. Genetic Analysis AS New infant gut microbiota screening test provides key tool for disease development investigation. Medial News Today 2009, http://www.medicalnewstoday.com/articles/172575.php.
13. Dethlefsen L., McFall-Ngai M., Relman D.A. An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature 2007, 449:811-818.
14. Shanahan F., Stanton C., Ross P., Hill C. Pharmabiotics: Bioactives from Mining Host-Microbe-Dietary Interactions. Funct Food Rev 2009, 1:1-6.
15. Wall R., Ross R.P., Ryan C.A., Hussey S., Murphy B., Fitzgerald G.F., Stanton C. Role of gut microbiota in early infant development. Clin Med: Pediatr 2009, 3:45-54.
16. Kovatcheva-Datchary P., Zoetendal E.G., Venema K., de Vos W.M., Smidt H. Review: tools for the tract: understanding the functionality of the gastrointestinal tract. Ther Adv Gastroenterol 2009, 2:s9-s22.
17. Resta S.C. Effects of probiotics and commensals on intestinal epithelial physiology: implications for nutrient handling. J Physiol 2009, 587:4169-4174.
18. Kelly D., King T., Aminov R. Importance of microbial colonization of the gut in early life to the development of immunity. Mutat Res 2007, 622:58-69.
19. Gottrand F. Long-chain polyunsaturated fatty acids influence the immune system of infants. J Nutr 2008, 138:1807S-1812.
20. Conroy M.E., Shi H.N., Walker W.A. The long-term health effects of neonatal microbial flora. Curr Opin Allergy Clin Immunol 2009, 9:197-201.
21. Wang M., Karlsson C., Olsson C., Adlerberth I., Wold A.E., Strachan D.P., Martricardi P.M., Aberg N., Perkin M.R., Tripodi S., et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol 2008, 121:129-134.
22. Saulnier D.M.A., Spinler J.K., Gibson G.R., Versalovic J. Mechanisms of probiosis and prebiosis: considerations for enhanced functional foods. Curr Opin Biotechnol 2009, 20:135-141.
23. Parracho H., McCartney A.L., Gibson G.R. Probiotics and prebiotics in infant nutrition. Proc Nutr Soc 2007, 66:405-411.
24. O'Hara A., Shanahan F. Mechanisms of action of probiotics in intestinal diseases. TheScientificWorldJOURNAL 2007, 7:31-46.
25. Jiménez E., Marín M.L., Martín R., Odriozola J.M., Olivares M., Xaus J., Fernández L., Rodríguez J.M. Is meconium from healthy newborns actually sterile?. Res Microbiol 2008, 159:187-193.
26. Satokari R., Grönroos T., Laitinen K., Salminen S., Isolauri E. Bifidobacterium and Lactobacillus DNA in the human placenta. Lett Appl Microbiol 2009, 48:8-12.
27. DiGiulio D.B., Romero R., Amogan H.P., Kusanovic J.P., Bik E.M., Gotsch F., Kim C.J., Erez O., Edwin S., Relman D.A. Microbial prevalence, diversity and abundance in amniotic fluid during preterm labor: a molecular and culture-based investigation. PLoS ONE 2008, 3:e3056.
28. Reinhardt C., Reigstad C.S., Bäckhed F. Intestinal microbiota during infancy and its implications for obesity. J Pediatr Gastroenterol Nutr 2009, 48:249-256.
29. Adlerberth I., Wold A. Establishment of the gut microbiota in Western infants. Acta Paediatr 2009, 98:229-238.
30. Morelli L. Postnatal development of intestinal microflora as influenced by infant nutrition. J Nutr 2008, 138:1791S-1795S.
31. Biasucci G., Benenati B., Morelli L., Bessi E., Boehm G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr 2008, 138:1796S-1800S.
32. Butel M.-J., Suau A., Campeotto F., Magne F., Aires J., Ferraris L., Kalach N., Leroux B., Dupont C. Conditions of bifidobacterial colonization in preterm infants: a prospective analysis. J Pediatr Gastroenterol Nutr 2007, 44:577-582.
33. Martin C.R., Walker W.A. Probiotics: role in pathophysiology and prevention in necrotizing enterocolitis. Semin Perinatol 2008, 32:127-137.
34. Martin R., Jimenez E., Heilig H., Fernandez L., Marin M.L., Zoetendal E.G., Rodriguez J.M. Isolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-DGGE and qRTi-PCR. Appl Environ Microbiol 2008, 75:965-969.
35. Boehm G., Moro G. Structural and functional aspects of prebiotics used in infant nutrition. J Nutr 2008, 138:1818S-1828S.
36. Mshvildadze M., Neu J., Mai V. Intestinal microbiota development in the premature neonate: establishment of a lasting commensal relationship?. Nutr Rev 2008, 66:658-663.
37. Round J.L., Mazmanian S.K. The gut microbiota shapes intestinal immune responses during health and disease. Nat Rev Immunol 2009, 9:313-323.
38. Macpherson A.J., Harris N.L. Interactions between commensal intestinal bacteria and the immune system. Nat Rev Immunol 2004, 4:478-485.
39. Mazmanian S.K., Liu C.H., Tzianabos A.O., Kasper D.L. An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell 2005, 122:107-118.
40. Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: human gut microbes associated with obesity. Nature 2006, 444:1022-1023.
41. Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006, 444:1027-1131.
42. Backhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004, 101:15718-15723.
43. Cani P.D., Bibiloni R., Knauf C., Waget A., Neyrinck A.M., Delzenne N.M., Burcelin R.M. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet induced obesity and diabetes in mice. Diabetes 2008, 57:1470-1481.
44. Dumas M.-E., Barton R.H., Toye A., Cloarec O., Blancher C., Rothwell A., Fearnside J., Tatoud R., Blanc V.R., Lindon J.C., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc Natl Acad Sci 2006, 103:12511-12516.
45. Kalliomaki M., Carmen Collado M., Salminen S., Isolauri E. Early differences in fecal microbiota composition in children may predict overweight. Am J Clin Nutr 2008, 87:534-538.
46. Wall R., Ross R.P., Shanahan F., O'Mahony L., O'Mahony C., Coakley M., Hart O., Lawlor P., Quigley E.M., Kiely B., et al. Metabolic activity of the enteric microbiota influences the fatty acid composition of murine and porcine liver and adipose tissues. Am J Clin Nutr 2009, 89:1393-1401.
47. Oresic M., Seppänen-Laakso T., Yetukuri L., Bäckhed F., Hänninen V. Gut microbiota affects lens and retinal lipid composition. Exp Eye Res 2009, 89:604-607.
48. Forsythe P, Sudo N, Dinan T, Taylor VH, Bienenstock J: Mood and gut feelings. Brain, Behav, Immun 2010, 24:9-16.
49. Mazmanian S.K., Round J.L., Kasper D.L. A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 2008, 453:620-625.
50. Shanahan F., Kiely B. The gut microbiota and disease-an inner repository for drug discovery. Drug Discov Today: Ther Strat 2007, 4:195-200.
51. Puccio G., Cajozzo C., Meli F., Rochat F., Grathwohl D., Steenhout P. Clinical evaluation of a new starter formula for infants containing live Bifidobacterium longum BL999 and prebiotics. Nutrition 2007, 23:1-8.
52. Maslowski K.M., Vieira A.T., Ng A., Kranich J., Sierro F., Yu D., Schilter H.C., Rolph M.S., Mackay F., Artis D., et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature 2009, 461:1282-1286.
53. Greer FR: Vitamin K the basics-What's new? Early Hum Dev 2010, in press. doi:10.1016/j.earlhumdev.2010.01.015.
54. Schurgers L.J., Teunissen K.J.F., Hamulyak K., Knapen M.H.J., Vik H., Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood 2007, 109:3279-3283.
55. Hojo K., Watanabe R., Mori T., Taketomo N. Quantitative measurement of tetrahydromenaquinone-9 in cheese fermented by propionibacteria. J Dairy Sci 2007, 90:4078-4083.
56. van Summeren M.J.H., Braam LAJLM, Lilien M.R., Schurgers L.J., Kuis W., Vermeer C. The effect of menaquinone-7 (vitamin K2) supplementation on osteocalcin carboxylation in healthy prepubertal children. Br J Nutr 2009, 102:1171-1178.
57. Kaneda M., Zhang D., Bhattacharjee R., Nakahama K.-I., Arii S., Morita I. Vitamin K2 suppresses malignancy of HuH7 hepatoma cells via inhibition of connexin 43. Cancer Lett 2008, 263:53-60.
58. Martens J.H., Barg H., Warren M.J., Jahn D. Microbial production of vitamin B12. Appl Microbiol Biotechnol 2002, 58:275-285.
59. 12 producer Lactobacillus reuteri JCM1112. Appl Environ Microbiol 2008, 74:3291-3294.
60. Hay G., Johnston C., Whitelaw A., Trygg K., Refsum H. Folate and cobalamin status in relation to breastfeeding and weaning in healthy infants. Am J Clin Nutr 2008, 88:105-114.
61. 12 deficiency on neurodevelopment in infants: current knowledge and possible mechanisms. Nutr Rev 2008, 66:250-255.
62. Bjorke-Monsen A.-L., Torsvik I., Saetran H., Markestad T., Ueland P.M. Common metabolic profile in infants indicating impaired cobalamin status responds to cobalamin supplementation. Pediatrics 2008, 122:83-91.
63. Ross R.P., Mills S., Hill C., Fitzgerald G.F., Stanton C. Specific metabolite production by gut microbiota as a basis for probiotic function. Int Dairy J 2010, 20:269-276.
64. Bhattacharya A., Banu J., Rahman M., Causey J., Fernandes G. Biological effects of conjugated linoleic acids in health and disease. J Nutr Biochem 2006, 17:789-810.
65. Rosberg-Cody E., Ross R.P., Hussey S., Ryan C.A., Murphy B.P., Fitzgerald G.F., Devery R., Stanton C. Mining the microbiota of the neonatal gastrointestinal tract for conjugated linoleic acid-producing bifidobacteria. Appl Environ Microbiol 2004, 70:4635-4641.
66. Huang J., Mei L.-H., Wu H., Lin D.-Q. Biosynthesis of γ-aminobutyric acid (GABA) using immobilized whole cells of Lactobacillus brevis. World J Microbiol Biotechnol 2007, 23:865-871.
67. Komatsuzaki N., Nakamura T., Kimura T., Shima J. Characterization of glutamate decarboxylase from a high gamma-aminobutyric acid (GABA)-producer, Lactobacillus paracasei. Biosci, Biotechnol, Biochem 2008, 72:278-285.
68. Park K.-B., Oh S.-H. Production of yogurt with enhanced levels of gamma-aminobutyric acid and valuable nutrients using lactic acid bacteria and germinated soybean extract. Bioresour Technol 2007, 98:1675-1679.
69. Mazmanian S.K., Kasper D.L. The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol 2006, 6:849-858.
70. Parker P., Jones G., Smith S. Mixed cultures of food-grade probiotic bacteria and enteric bacteria demonstrate both synergism and inhibition of menaquinone production. J Food Sci 2003, 68:2325-2330.
71. Barrett E., Ross R.P., Fitzgerald G.F., Stanton C. Rapid screening method for analysing the conjugated linoleic acid production capabilities of bacterial cultures. Appl Environ Microbiol 2007, 73:2333-2337.
72. Singhal A., Macfarlane G., Macfarlane S., Lanigan J., Kennedy K., Elias-Jones A., Stephenson T., Dudek P., Lucas A. Dietary nucleotides and fecal microbiota in formula-fed infants: a randomized controlled trial. Am J Clin Nutr 2008, 87:1785-1792.
73. M'Rabet L., Vos A.P., Boehm G., Garssen J. Breast-feeding and its role in early development of the immune system in infants: consequences for health later in life. J Nutr 2008, 138:1782S-1790S.
74. Martín R., Heilig G.H.J., Zoetendal E.G., Smidt H., Rodríguez J.M. Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J Appl Microbiol 2007, 103:2638-2644.
75. FAO/WHO Report on Joint FAO/WHO Expert Consultation on Evaluation of Health and Nutritional Properties of Probiotics in Food including Powder Milk with Live Lactic Acid Bacteria 2001, ftp://ftp.fao.org/docrep/fao/009/a0512e/a0512e00.pdf.
76. Deshpande G., Rao S., Patole S. Probiotics for prevention of necrotising enterocolitis in preterm neonates with very low birthweight: a systematic review of randomised controlled trials. Lancet 2007, 369:1614-1620.
77. AlFaleh K.M., Bassler D. Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2008, Issue 1.. Art. No.: CD005496.
78. Mc Gee R, O'Connor PM, Russell D, Dempsey G, Ryan CA, Ross RP, Stanton C: Prolonged faecal excretion following a single dose of probiotic in low birth weight infants. Acta Paediatr 2010, in press.